{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:16:53Z","timestamp":1788527813457,"version":"build-2803163510"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Individualized prediction of relapse-related outcomes may support treatment selection and monitoring in relapsing multiple sclerosis. However, existing studies differ substantially in clinical purpose, target outcomes, modeling approaches, and validation strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review in accordance with PRISMA 2020. PubMed, Web of Science, IEEE Xplore, and Scopus were searched for English-language records published from 1 January 2010 to 14 January 2026. Studies developing or evaluating models for relapse or relapse-related outcomes in relapsing multiple sclerosis were included. Data on study design, predictors, modeling approach, target outcome, calibration, and validation were extracted. Owing to clinical and methodological heterogeneity, a structured narrative synthesis was performed. The protocol was registered in PROSPERO (CRD42024625392).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fourteen studies were included: five conventional relapse-prognosis studies, four individualized treatment-effect prediction studies, and five exploratory relapse-related studies. Clinically interpretable models based on structured clinical data generally demonstrated moderate discrimination but more transparent validation. Studies reporting very high predictive performance were commonly based on smaller samples, high-dimensional data, or limited independent validation. Calibration and external validation were inconsistently reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Relapse-related prediction in multiple sclerosis is feasible, but current evidence remains heterogeneous and insufficiently validated for routine clinical implementation. Progress will require harmonized outcome definitions, consistent calibration reporting, transparent model evaluation, and external validation across clinically diverse populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1940704","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:35:42Z","timestamp":1788525342000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Relapse prediction and individualized treatment-effect modeling in relapsing multiple sclerosis: a systematic review"],"prefix":"10.3389","volume":"14","author":[{"given":"Martin","family":"Budil","sequence":"first","affiliation":[{"name":"Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague","place":["Kladno, Czechia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ro\u017e\u00e1nek","sequence":"additional","affiliation":[{"name":"Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague","place":["Kladno, Czechia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Petrov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague","place":["Kladno, Czechia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"106540","DOI":"10.1016\/j.msard.2025.106540","article-title":"Decoding disease burden in multiple sclerosis: the role of IL-10 as biomarker of neuroinflammation and neurodegeneration","volume":"100","author":"Khedr","year":"2025","journal-title":"Mult Scler Relat Disord."},{"key":"B2","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/imj.70023","article-title":"Advancements in multiple sclerosis","volume":"55","author":"Montague","year":"2025","journal-title":"Intern Med J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12883-025-04338-7","article-title":"Comparative effectiveness of disease-modifying therapies for highly active relapsing-remitting multiple sclerosis despite previous treatment - a systematic review and network meta-analysis","volume":"25","author":"K\u00f6hler","year":"2025","journal-title":"BMC Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"106507","DOI":"10.1016\/j.msard.2025.106507","article-title":"Multiple sclerosis relapse incomplete recovery and associated factors \u2013 a systematic review and meta-analysis","volume":"100","author":"Ladeira","year":"2025","journal-title":"Mult Scler Relat Disord."},{"key":"B5","doi-asserted-by":"publisher","first-page":"111210","DOI":"10.1016\/j.jocn.2025.111210","article-title":"Clinical and psychological factors associated with fear of relapse in people with multiple sclerosis: a cross-sectional study","volume":"135","author":"Moases Ghaffary","year":"2025","journal-title":"Journal of Clinical Neuroscience."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s00415-023-12021-5","article-title":"Identification and management of subclinical disease activity in early multiple sclerosis: a review","volume":"271","author":"Ontaneda","year":"2024","journal-title":"J Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"125756","DOI":"10.1016\/j.jns.2026.125756","article-title":"Directions for advancing prognostic assessments in multiple sclerosis: qualitative Insights from MS specialist Interviews","volume":"481","author":"Aerts","year":"2026","journal-title":"J Neurol Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/sclerosis3020015","article-title":"Harnessing artificial intelligence for the diagnosis, treatment and research of multiple sclerosis","volume":"3","author":"Patil","year":"2025","journal-title":"Sclerosis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/01616412.2025.2532038","article-title":"AI-powered disease progression prediction in multiple sclerosis using magnetic resonance imaging: a systematic review and meta-analysis","volume":"48","author":"Houshi","year":"2026","journal-title":"Neurol Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"CD013606","DOI":"10.1002\/14651858.CD013606.pub2","article-title":"Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis","volume":"2023","year":"2023","journal-title":"Cochrane Database Syst Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"B12","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/acn3.51324","article-title":"Leveraging electronic health records data to predict multiple sclerosis disease activity","volume":"8","author":"Ahuja","year":"2021","journal-title":"Ann Clin Transl Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s41512-021-00106-6","article-title":"Development, validation and clinical usefulness of a prognostic model for relapse in relapsing-remitting multiple sclerosis","volume":"5","author":"Chalkou","year":"2021","journal-title":"Diagn Progn Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"101349","DOI":"10.1016\/j.imu.2023.101349","article-title":"Explainable Artificial Intelligence to predict clinical outcomes in type 1 diabetes and relapsing-remitting multiple sclerosis adult patients","volume":"42","author":"Ihalapathirana","year":"2023","journal-title":"Inform Med Unlocked."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1109\/ICWR57742.2023.10139225","article-title":"Supervised Machine Learning Models for Multiple Sclerosis Relapse Probability Prognosis using Clinical Data","author":"Vakili","year":"2023","journal-title":"2023 9th International Conference on Web Research (ICWR)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"103330","DOI":"10.1016\/j.msard.2021.103330","article-title":"Comparing traditional modeling approaches versus predictive analytics methods for predicting multiple sclerosis relapse","volume":"57","author":"Walsh","year":"2022","journal-title":"Mult Scler Relat Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1002\/sim.9034","article-title":"Two-stage prediction model for heterogeneous effects of treatments","volume":"40","author":"Chalkou","year":"2021","journal-title":"Stat Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"106247","DOI":"10.1016\/j.msard.2024.106247","article-title":"Multivariable prognostic prediction of efficacy and safety outcomes and response to fingolimod in people with relapsing-remitting multiple sclerosis","volume":"93","author":"Irmak \u00d6n","year":"2025","journal-title":"Mult Scler Relat Disord."},{"key":"B19","doi-asserted-by":"publisher","first-page":"20552173231194353","DOI":"10.1177\/20552173231194353","article-title":"Overall and patient-specific comparative effectiveness of dimethyl fumarate versus teriflunomide: a novel approach to precision medicine applied to the German NeuroTrans Data Multiple Sclerosis Registry","volume":"9","author":"Jiang","year":"2023","journal-title":"Mult Scler J Exp Transl Clin."},{"key":"B20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12874-020-0906-6","article-title":"Framework for personalized prediction of treatment response in relapsing remitting multiple sclerosis","volume":"20","author":"St\u00fchler","year":"2020","journal-title":"BMC Med Res Methodol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1471-2377-11-67","article-title":"Computational classifiers for predicting the short-term course of Multiple sclerosis","volume":"11","author":"Bejarano","year":"2011","journal-title":"BMC Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1111\/ene.15009","article-title":"Plasma neurofilament light chain concentrations as a biomarker of clinical and radiologic outcomes in relapsing multiple sclerosis: Post hoc analysis of Phase 3 ozanimod trials","volume":"28","author":"Harris","year":"2021","journal-title":"Eur J Neurol."},{"key":"B23","unstructured":"\u201cUsing Wearable and Environmental Data to Improve the Prediction of Amyotrophic Lateral Sclerosis and Multiple Sclerosis Progression: an Explorative Study\n          \n          \n            \n              Marinello\n              E\n            \n            \n              Guazzo\n              A\n            \n            \n              Longato\n              E\n            \n            \n              Tavazzi\n              E\n            \n            \n              Trescato\n              I\n            \n            \n              Vettoretti\n              M\n            \n          \n          \n          2024"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1109\/BIBM62325.2024.10822214","article-title":"Machine Learning Models Highlight the Impact of Pollution and Weather Patterns on Relapse Occurrence in Multiple Sclerosis Patients","author":"Marinello","year":"2024","journal-title":"2024 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"104750","DOI":"10.1016\/j.msard.2023.104750","article-title":"Deep learning-based PET\/MR radiomics for the classification of annualized relapse rate in multiple sclerosis","volume":"75","author":"Du","year":"2023","journal-title":"Mult Scler Relat Disord."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1712953","DOI":"10.3389\/fneur.2025.1712953","article-title":"Predicting multiple sclerosis prognosis using AI and machine learning: integrating clinical, immunological, and radiological variables","volume":"16","author":"Al-Shammri","year":"2026","journal-title":"Front Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"fcaf243","DOI":"10.1093\/braincomms\/fcaf243","article-title":"Deep learning to predict progression independent of relapse activity at a first demyelinating event","volume":"7","author":"Coll","year":"2025","journal-title":"Brain Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"i6460","DOI":"10.1136\/bmj.i6460","article-title":"A guide to systematic review and meta-analysis of prediction model performance","volume":"356","author":"Debray","year":"2017","journal-title":"BMJ."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e074821","DOI":"10.1136\/bmj-2023-074821","article-title":"Evaluation of clinical prediction models (part 3): calculating the sample size required for an external validation study","volume":"384","author":"Riley","year":"2024","journal-title":"BMJ."},{"key":"B31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the Achilles heel of predictive analytics","volume":"17","author":"Van Calster","year":"2019","journal-title":"BMC Med."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-39355-6_10","article-title":"\u201cOverfitting, Underfitting and General Model Overconfidence and Under-Performance Pitfalls and Best Practices in Machine Learning and AI","author":"Aliferis","year":"2024","journal-title":"Artificial Intelligence and Machine Learning in Health Care and Medical Sciences"},{"key":"B33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41746-024-01127-3","article-title":"Generalization\u2014a key challenge for responsible AI in patient-facing clinical applications","volume":"7","author":"Goetz","year":"2024","journal-title":"npj Digit Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0298328","DOI":"10.1371\/journal.pone.0298328","article-title":"Suboptimal capability of individual machine learning algorithms in modeling small-scale imbalanced clinical data of local hospital","volume":"19","author":"Li","year":"2024","journal-title":"PLoS One."},{"key":"B35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41746-024-01360-w","article-title":"Estimation of minimal data sets sizes for machine learning predictions in digital mental health interventions","volume":"7","author":"Zantvoort","year":"2024","journal-title":"npj Digit Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"102972","DOI":"10.1016\/j.nicl.2022.102972","article-title":"MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies","volume":"34","author":"De Stefano","year":"2022","journal-title":"Neuroimage Clin."},{"key":"B37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/medicina58030377","article-title":"Predictive MRI biomarkers in MS\u2014a critical review","volume":"58","author":"Tiu","year":"2022","journal-title":"Medicina."},{"key":"B38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.msard.2019.08.003","article-title":"Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: data from the national registry ReMuS","volume":"35","author":"Horakova","year":"2019","journal-title":"Mult Scler Relat Disord."},{"key":"B39","doi-asserted-by":"publisher","first-page":"262","DOI":"10.5507\/bp.2023.015","article-title":"The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021","volume":"168","author":"Stastna","year":"2024","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub."},{"key":"B40","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/13524585231216004","article-title":"Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task force","volume":"30","author":"Parciak","year":"2024","journal-title":"Mult Scler."},{"key":"B41","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s00415-025-13439-9","article-title":"Big multiple sclerosis data network: novel modelling approaches for real-world data analysis","volume":"272","author":"Trojano","year":"2025","journal-title":"J Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1038\/s41591-025-03901-6","article-title":"AI-driven reclassification of multiple sclerosis progression","volume":"31","author":"Ganjgahi","year":"2025","journal-title":"Nat Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e078276","DOI":"10.1136\/bmj-2023-078276","article-title":"Developing clinical prediction models: a step-by-step guide","volume":"386","author":"Efthimiou","year":"2024","journal-title":"BMJ."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e100784","DOI":"10.1136\/bmjhci-2023-100784","article-title":"Road map for clinicians to develop and evaluate AI predictive models to inform clinical decision-making","volume":"30","author":"Hassan","year":"2023","journal-title":"BMJ Health Care Inform."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e081554","DOI":"10.1136\/bmj-2024-081554","article-title":"FUTURE-AI: international consensus guideline for trustworthy and deployable artificial intelligence in healthcare","volume":"388","author":"Lekadir","year":"2025","journal-title":"BMJ."},{"key":"B46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41746-024-01037-4","article-title":"Why do probabilistic clinical models fail to transport between sites","volume":"7","author":"Lasko","year":"2024","journal-title":"NPJ Digit Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e048008","DOI":"10.1136\/bmjopen-2020-048008","article-title":"Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence","volume":"11","author":"Collins","year":"2021","journal-title":"BMJ Open."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00415-023-12132-z","article-title":"Predicting disease severity in multiple sclerosis using multimodal data and machine learning","volume":"271","author":"Andorra","year":"2024","journal-title":"J Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"6543","DOI":"10.1007\/s00415-024-12651-3","article-title":"Predicting multiple sclerosis disease progression and outcomes with machine learning and MRI-based biomarkers: a review","volume":"271","author":"Yousef","year":"2024","journal-title":"J Neurol."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1940704\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:35:43Z","timestamp":1788525343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1940704\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":49,"alternative-id":["10.3389\/fpubh.2026.1940704"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1940704","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"article-number":"1940704"}}